{
    "SPADE_UN_13446": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13446",
            "Peptide Name": "CPF-14 (Variant of CPF-C1)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "N/A",
            "Sequence": "GFGSLLGKALRLWKKVL",
            "Sequence Length": 17,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+"
            ],
            "Target Organism": "[Ref.32590058] Gram-positive:S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 4 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 32 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 8 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 8 μg/mL), S. aureus 794 (MIC = 8 μg/mL)",
            "Hemolytic Activity": "[Ref.32590058]It exhibited low hemolytic activity against mouse RBCs. CPF-14 displayed 4% and 13% hemolysis at the concentration of 64 and 128 μg/mL",
            "Cytotoxicity": "Not found",
            "Binding Target": "Bacterial membrane",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "Mixed (D-Trp13 and D-Lys15)",
            "Structure Description": "Not found",
            "Formula": "C91H152N24O19",
            "Mass": 1886.33,
            "PI": 11.26,
            "Net Charge": 4,
            "Hydrophobicity": 0.51,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "CPF-14 showed improved antimicrobial activities against S. aureus and stabilities in serum and salt solution.",
            "Literature": [
                {
                    "Title": "CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA",
                    "Pubmed ID": "32590058",
                    "Reference": "Biochimie. 2020 Sep;1761-11. doi 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.",
                    "Author": "Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32590058"
                }
            ],
            "Frequent Amino Acids": "LGK",
            "Absent Amino Acids": "CDEHIMNOPQTUY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 7,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13446",
                    "Similarity": 1.0,
                    "Sequence": "GFGSLLGKALRLWKKVL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13447",
                    "Similarity": 1.0,
                    "Sequence": "GFGSLLGKALRLWKKVL"
                },
                {
                    "SPADE_ID": "SPADE_UN_22428",
                    "Similarity": 1.0,
                    "Sequence": "RLWKIGKVLKWI"
                }
            ]
        }
    }
}